CGI Group (GIB) to acquire Unico

CGI (NYSE: GIB) (TSX: GIB.A) today announces that its subsidiary, CGI Technology and Solutions Australia Pty Limited, has signed an agreement to acquire Unico, a technology consultancy and systems integrator based in Melbourne, Australia. The transaction is subject to approval by Australia's Foreign Investment Review Board and is expected to close sometime next quarter.

The acquisition will grow CGI's footprint in Australia, with a focus on the Melbourne metro market, and in key industry sectors, including communications, government, utilities and financial services.

Unico, which was established in 1984, brings approximately 160 largely Melbourne-based professionals to CGI. The team will be integrated with CGI's existing business in Australia, which forms part of the UK and Australia Strategic Business Unit.

"We look forward to welcoming Unico into the CGI family," said Tara McGeehan, CGI's UK & Australia President. "Right from our earliest discussions, it's been clear that both organisations share similar values and capabilities, which we believe will result in a quick and successful integration. Here in the UK & Australia business, we pride ourselves on being a responsible business that does complex things well—and Unico shares a similar ethos. We are excited to bring together our expertise and innovation to build an even stronger presence in the Australian market."

The merger, combined with the recent opening of CGI's Space, Defence and Intelligence Hub in Adelaide, will enhance and accelerate CGI's position in Australia as a leading provider of secure and flexible end-to-end services, including business and strategic IT consulting, systems integration, managed services and intellectual property-based business solutions.

You May Also Be Interested In

• Bunge Limited (BG) and Viterra Issue Statement on Canadian Competition Bureau Report
• TopBuild (BLD) Announces Mutual Termination of Deal to Acquire Specialty Products and Insulation
• KKR & Co. (KKR) agreed to acquire Immedica Pharma